Background: To our knowledge, no analysis of data from liver transplantation registries
exists in Canada. We aimed to describe temporal trends in the number of liver …

The aim of this study was to analyze longterm patient and graft survival after liver
transplantation for autoimmune hepatitis (AIH‐LT) from the prospective multicenter …

Background Patients with autoimmune hepatitis (AIH) may co-present with features of
primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC). Using a national …

Background: Autoimmune liver diseases, namely primary biliary cholangitis (PBC), primary
sclerosing cholangitis (PSC), and autoimmune hepatitis (AIH) generally have favorable …

Autoimmune liver diseases (ALDs), including autoimmune hepatitis (AIH), primary
sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC), are an indication for liver …

Background Living donor liver transplantation (LDLT) offers the opportunity to decrease
waitlist time and mortality for patients with AILD; autoimmune hepatitis (AIH), primary biliary …

Background & Aims The rarity of autoimmune liver disease poses challenges to
epidemiology studies. However, waitlists for liver transplantation can be used to study …

The principal aim of this study was to compare the probability of and potential risk factors for
death and graft loss after primary adult and pediatric liver transplantation in patients …

Liver transplantation (LT) is the treatment of choice for end-stage autoimmune liver
diseases. However, the underlying disease may recur in the graft in some 20% of cases. The …

Abstract Introduction and Objectives Autoimmune liver diseases (AILDs): autoimmune
hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) …